Ulcer, drainage, fistula

[Clin Infect Dis 2023; ciad527, https://doi.org/10.1093/cid/ciad527]

 

- Monitor renal function and adjust dosing of antibiotics according to renal function.

- Switch to oral therapy should be guided by clinical improvement and deep tissue culture & susceptibility results.

 
Usual Pathogens
Polymicrobial:

S. aureus/MRSA
S. epidermidis
ß-haemolytic Streptococci (group A,B,C,G)
Enterococcus spp
Enterobacterales
Pseudomonas spp
Anaerobes (cover if chronic or necrotic, foul-smelling infection, or if peripheral vascular disease)

Debridement & Glycemic control

Mild

Empiric Therapy

Dose

Duration
Amoxicillin-clavulanate 875mg PO bid

7-10 days

 

Penicillin/amoxicillin allergy

Empiric Therapy

Dose

Duration
Cefuroxime axetil 500mg PO bid 7-10 days
+    
Metronidazole 500mg PO bid  

Cefuroxime allergy

Empiric Therapy

Dose

Duration
Doxycycline 100mg PO bid

7-10 days

+    
Metronidazole 500mg PO bid  

MRSA suspected

Empiric Therapy

Dose

Duration
Amoxicillin-clavulanate 875mg PO bid

7-10 days

+  

 

TMP/SMX 2DS tabs PO bid

 

Amoxicillin/penicillin allergy  

 

Doxycycline 100mg PO bid

7-10 days

+  

 

Metronidazole 500mg PO bid

 

 

Moderate-severe

Empiric Therapy

Dose

Duration
Cefazolin 2g IV q8h

10 days

+    
Metronidazole 500mg PO bid  

Cefazolin allergy

Empiric Therapy

Dose

Duration
Ceftriaxone 2g IV daily 10 days
+    
Metronidazole IV/PO 500mg PO/IV q12h  

 

Outpatient and failure of oral therapy or known/suspected ESBL/Amp C-producing organisms or ceftriaxone-resistant organisms

Empiric Therapy

Dose

Duration
Ertapenem 1g IV daily 2-3 weeks

MRSA suspected - Moderate-severe

Empiric Therapy

Dose

Duration
Vancomycin 15mg/kg IV q12h 2-3 weeks
+    
Ceftriaxone 1g IV daily  
+    
Metronidazole IV/PO 500mg PO/IV q12h  

Limb-threatening

Empiric Therapy Dose Duration
Piperacillin-tazobactam 3.375g IV q6h 2-3 weeks
+    
Vancomycin 15mg/kg IV q12h  
Penicillin allergy    
Meropenem 500mg IV q6h

2-3 weeks

+    
Vancomycin 15mg/kg IV q12h